NILOTHERAPY 150

NILOTHERAPY 150 is a targeted anticancer medication formulated with Nilotinib (150 mg), specifically designed for the effective management of chronic myeloid leukemia (CML). Developed by Steris Healthcare Pvt. Ltd., this advanced therapy offers precision treatment by targeting cancer-causing proteins, helping to control disease progression and improve patient outcomes.

What is NILOTHERAPY 150?

NILOTHERAPY 150 contains Nilotinib (150 mg), a second-generation tyrosine kinase inhibitor (TKI). It is widely used in the treatment of Philadelphia chromosome-positive (Ph+ CML), a type of blood cancer characterized by the uncontrolled growth of abnormal white blood cells.

This medication is particularly beneficial for patients who are newly diagnosed or those who have shown resistance or intolerance to previous therapies such as imatinib.

How NILOTHERAPY 150 Works

Chronic myeloid leukemia is caused by a genetic abnormality that produces the BCR-ABL tyrosine kinase protein, which drives cancer cell multiplication. Nilotinib in NILOTHERAPY 150 works by selectively inhibiting this protein, thereby blocking the growth and spread of cancer cells.

By targeting the root cause of the disease, NILOTHERAPY 150 helps in reducing the number of abnormal cells and supports the restoration of normal blood cell production.

Key Benefits of NILOTHERAPY 150

• Targeted Therapy for CML: Acts directly on cancer-causing proteins
• Effective Disease Control: Helps slow or stop leukemia progression
• Improved Patient Outcomes: Enhances long-term survival rates
• Better Tolerability: Compared to conventional chemotherapy
• Flexible Dosing Strength: Suitable for dose adjustment and individualized therapy
• Supports Quality of Life: Enables patients to manage daily activities

Uses of Nilotinib (150 mg)

NILOTHERAPY 150 is prescribed for:

• Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
• Patients resistant or intolerant to prior treatment
• Management of chronic and accelerated phases of CML
• Dose adjustment in ongoing Nilotinib therapy

Dosage and Administration

NILOTHERAPY 150 should be used strictly under the supervision of an oncologist.

General Guidelines:

• Usually taken twice daily
• Must be taken on an empty stomach (avoid food 2 hours before and 1 hour after)
• Swallow capsules whole with water
• Do not crush, chew, or open the capsules

The dosage is determined based on the patient’s clinical condition, response to treatment, and tolerability.

Important Precautions

Before starting NILOTHERAPY 150, inform your doctor about:

• Heart problems, especially QT prolongation
• Liver or pancreatic disorders
• Electrolyte imbalances
• History of bleeding or clotting disorders

Precautionary Measures:

• Regular ECG monitoring is recommended
• Routine blood tests are required to monitor liver function and blood counts
• Avoid grapefruit and its juice during treatment
• Use effective contraception during treatment

Possible Side Effects

Like other anticancer drugs, NILOTHERAPY 150 may cause side effects, although not everyone experiences them.

Common Side Effects:

• Nausea and vomiting
• Fatigue
• Headache
• Skin rash or itching
• Constipation or diarrhea

Serious Side Effects:

• Irregular heartbeat (QT prolongation)
• Liver toxicity
• Pancreatitis
• Low blood cell counts

Seek immediate medical attention if any severe symptoms occur.

Storage Instructions

• Store below 25°C in a cool, dry place
• Keep away from direct sunlight and moisture
• Keep out of reach of children

Why Choose NILOTHERAPY 150?

NILOTHERAPY 150 by Steris Healthcare Pvt. Ltd. is manufactured under strict quality standards to ensure safety, efficacy, and consistency. It is designed to meet the evolving needs of cancer care, offering a reliable and affordable option for patients in India.

Its targeted mechanism, flexible dosing strength, and proven clinical benefits make it a preferred choice for oncologists managing chronic myeloid leukemia.

Conclusion

NILOTHERAPY 150 (Nilotinib 150 mg) is a modern, targeted anticancer therapy that offers effective management of chronic myeloid leukemia. With its precise action, strong efficacy, and patient-friendly dosing, it plays a vital role in improving disease control and enhancing quality of life.

For best results, always use NILOTHERAPY 150 under expert medical guidance and follow recommended monitoring protocols to ensure safe and effective treatment.